UCLA INVENTS
driving innovation to market.
News Bulletin - March, 2013  
UCLA INVENTS is a monthly e-bulletin published by the Office of Intellectual Property (OIP) to highlight entrepreneurship, innovation, and technology commercialization at UCLA. [ how to subscribe ]
 
NanoSmart Pharmaceuticals Partners with UCLA to Develop Drug Delivery Technology
Collaboration to Develop Pediatric Cancer Treatment

LAGUNA HILLS, CA – NanoSmart® Pharmaceuticals, a private biotechnology company, has entered into a research collaboration agreement with University of California Los Angeles (UCLA) to continue the development of NanoSmart’s novel drug delivery platform for the treatment of cancer and other life-threatening diseases.

“We are very excited to work closely with Dr. Noah Federman and his colleagues at UCLA, as they will provide access to an extraordinary level of research, development and clinical resources,” said Dr. James Smith, President of NanoSmart Pharmaceuticals. “Their expertise in the development of nanotechnology-based drugs will enable us to continue making efficient progress towards commercializing these products...”

READ FULL ARTICLE ]
[ NanoSmart Pharma ]

~~~~~

OIP First Fridays Event - Recap
Research Funding Opportunities and Resources at UCLA.

Kinross Bldg
Our guest speaker for February’s First Friday’s event was Jill Sweitzer, Research Development Officer of the UCLA Office of the Vice Chancellor for Research.  Jill’s talk focused on research funding opportunities and the tools and resources available to UCLA researchers to help find funding. Some examples are provided below.

Federal grant opportunities can be found at http://grants.gov.  Depending on the researcher’s discipline, the Federal Government has a number of grants available.  Jill pointed out that it may also be a useful database for those located in North Campus, as there are often funding opportunities for programs such as language training and historical preservation.  In addition to Federal funding, UCLA researchers also have access to Pivot: https://pivot.cos.com/; Spin:  http://infoedglobal.com/soultions/spin-global-suite/ and GrantForward:  http://tinyurl.com/grantforward.  Jill noted that the databases, with over 40,000 funding opportunities, give different results from similar pools of information, and encouraged researchers to use all three databases to determine which one gives the best information for the project in question.

Federal Grants and database subscriptions notwithstanding, UCLA researchers also have access to a number of on-campus services including foundation opportunities ( http://tinyurl.com/uclacfrr ) and Jill herself jsweitzer@conet.ucla.edu at the Office of the Vice Chancellor for Research.

    ~~~~~

    NeuroSigma Announces Issued US Patent
    Patent Related to eTNS Technology for the Treatment of Neuropsychiatric Disorders.

    NeuroSigma, Inc., a California -based medical device company, announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application No. 12/898,686 entitled "Devices, Systems and Methods For Treatment of Neuropsychiatric Disorders."

    The patent application, exclusively licensed to NeuroSigma, is owned by The Regents of the University of California (Regents) as a result of research conducted by physicians and scientists at the University of California, Los Angeles (UCLA). Morgan, Lewis & Bockius LLP has represented the Regents in the prosecution of this patent application and other related applications. Haynes & Boone LLP has represented NeuroSigma.

    The method and system claims of the patent application cover the use of trigeminal nerve stimulation (TNS) with cutaneous electrodes for the treatment of neuropsychiatric disorders, including but not limited to mood, cognitive, behavioral and anxiety disorders...

    [ READ MORE ]
    [ NeuroSigma ]

    ~~~~~

    UCLA Entrepreneur Spotlight - Pallavi Patil 
    UCLA grad student launches VineLust, an e-commerce startup that aims to help  people explore wine using an algorithm.

    The golden age of the algorithm is now.

    As Netflix’s personalized video recommendation algorithm catalyzed mass online film distribution and Pandora Radio’s music recommendation algorithm redesigned the way people find new music, so is VineLust’s taste algorithm pioneering the way wine will be recommended and distributed.

    VineLust is a startup wine e-commerce business and the brainchild of founder Pallavi Patil, a graduate student in the UCLA Anderson School of Management as well as a self-described “foodie” and lover of wine. After completing her undergraduate education at New York University’s Stern School of Business, she spent the last five years working on Wall Street before coming to school at UCLA. During that time, Patil took many trips to Napa Valley and Santa Barbara, where she indulged her love of wine and dreamed up her own business: VineLust...

    [ READ FULL ARTICLE - Daily Bruin ]
    [ VineLust ]

    ~~~~~

    Newly Identified Natural Protein Blocks HIV, Other Deadly Viruses

    A team of UCLA-led researchers has identified a protein with broad virus-fighting properties that potentially could be used as a weapon against deadly human pathogenic viruses such as HIV, Ebola, Rift Valley Fever, Nipah and others designated "priority pathogens" for national biosecurity purposes by the National Institute of Allergy and Infectious Disease.
     
    In a study published in the January issue of the journal Immunity, the researchers describe the novel antiviral property of the protein, cholesterol-25-hydroxylase (CH25H), an enzyme that converts cholesterol to an oxysterol called 25-hydroxycholesterol (25HC), which can permeate a cell's wall and block a virus from getting in...

    [ READ FULL ARTICLE ]
    [ UCLA AIDS INSTITUTE ]
     

    ~~~~~

                    
    FEATURED
    EVENTS
    FIRST
    FRIDAY'S
    @ OIP


    April. 05, 2013 
    9am-10:30am
    Kinross Bldg., Suite 210

    THEME:  PortTechLA Innovation Center
    "Entrepreneurship and Research Collaboration."

    Guest Speaker:
    Stan Tomsic
    Executive Director
    PortTechLA

      RSVP:  [ registration  ]



    CTSI Open House

    Date: March 21, 2013
    Time: 3pm-5:30pm PST.

    The Westwood Clinical and Translational Research Center and Laboratory welcomes investigators, research teams, sponsors and other interested individuals to drop by to discuss your research and find out about resources available at our premier research facility. 

    For more Information and to RSVP by Monday, March 18th : Chen (Anna) Zheng at Czheng@mednet.ucla.edu


    CTSI [ web


    Startup Breakfast - CrossCampus and Caltech

    Mar. 09, 2013
    8:00am-12:00pm

    Attend a special breakfast panel engagement with the heads of six Internet startups that are putting Southern California on the Venture-Tech map.

          Info & Registration


    UCLA PATENTS
    Patent Image
    Latest UCLA patents issued by the USPTO:

    8,367,798  Active Materials for Photoelectric Devices and Devices that use the Materials | Yang Yang, et al.

    8,362,376  Electrostatically Driven High Speed Micro Droplet Switch | Chang-Jin Kim, et al.

    8,361,982  Method for Expression of Small Antiviral RNA Molecules with Reduced Cytotoxicity within a Cell | Irvin S.Y. Chen, et al.

    8,361,415  Inertial Particle Focusing System | Dino Di Carlo, et al.

    8,357,365  Granulysin Peptides and Methods of Use Thereof | Jenny Kim, et al.

    8,355,198  Method and Apparatus for Generation and Detection of Rogue Waves | Bahram Jalali, et al.

    8,354,583  Solar Cells Arrangement | Oscar Stafsudd, et al.

    8,351,529  Apparatus and Method for Detecting Communications from Multiple Sources | Michael Fitz, et al.

    FEATURED
    RESOURCES








     UCLA INVENTS Vol. 1, No. 7

    The UCLA INVENTS News Bulletin is published by UCLA's Office of Intellectual Property and Industry Sponsored Research (OIP-ISR). UCLA INVENTS highlights entrepreneurial and technology commercialization developments, and opportunities at UCLA.

    PLEASE ATTENTION editorial comments, corrections, and topic suggestions to:  
    Bob Nidever,   bnidever@research.ucla.edu


    Editor
      Bob Nidever

    Writer
      Erin Bowers

    Contributors 
      Neil Bajpayee
      Ben Dibling
      Steve Huyn

    To subscribe, please visit:   UCLAinvents.com   

    UCLA INVENTS
    UCLA Office of Intellectual Property and Industry Sponsored Research
    11000 Kinross Ave., Suite 200; Los Angeles, CA 90095 | tel. 310-794-0558 |  http://oip.ucla.edu

    Copyright 2013 UC Regents

    Share this